Ready-to-Use IVs

April 2021 : State of Pharmacy Compounding - Vol.18 No. 4 - Page #52
Category: IV Sets/Solutions

With their 100% user satisfaction rating, ready-to-use (RTU) IVs are popular products in the pharmacy. While they are most commonly assembled in a PEC in the cleanroom, 36% of users continue to assemble most of their RTU IVs on the nursing unit. Despite the significant value these products deliver, they typically account for less than 25% of the pharmacy’s total IV purchases.


A combination approach of utilizing both piggybacks and syringes is strongly favored by a clear majority.


Just under two-thirds of all facilities take advantage of point-of-care devices.


Baxter leads this marketplace, followed by B. Braun and ICU.


The RTU products marketplace is projected to enjoy strong growth as 45% of facilities plan to increase their utilization of these products over the next 3 years.


Baxter and B. Braun lead the vendors in use, followed by Fresenius Kabi, Pfizer, Teva, and Sagent.


2021 State Of Pharmacy Compounding Slides

Login

Like what you've read? Please log in or create a free account to enjoy more of what www.pppmag.com has to offer.

Current Issue